Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Published online first on April 21, 2009
[Cancer Research, 10.1158/0008-5472.CAN-09-0014]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-09-0014v1
69/9/3764    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Du, Q.
Right arrow Articles by Geller, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du, Q.
Right arrow Articles by Geller, D. A.

Cell, Tumor, and Stem Cell Biology

Wnt/{beta}-Catenin Signaling Regulates Cytokine-Induced Human Inducible Nitric Oxide Synthase Expression by Inhibiting Nuclear Factor-{kappa}B Activation in Cancer Cells

Qiang Du , Xinglu Zhang , Jon Cardinal , Zongxian Cao , Zhong Guo , Lifang Shao , and David A. Geller *

Department of Surgery, T.E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

* To whom correspondence should be addressed. E-mail: gellerda{at}upmc.edu.


   Abstract

The human inducible nitric oxide synthase (hiNOS) gene is regulated by nuclear factor {kappa}B (NF-{kappa}B) and has recently been shown to be a target of the Wnt/{beta}-catenin pathway. In this study, we tested the hypothesis that Wnt/{beta}-catenin signaling might regulate cytokine- or tumor necrosis factor {alpha} (TNF{alpha})–induced hiNOS expression through interaction with NF-{kappa}B. A cytokine mixture of TNF{alpha} + interleukin (IL)-1{beta} + IFN{gamma} induced a 2- to 3-fold increase in hiNOS promoter activity in HCT116 and DLD1 colon cells, but produced a 2-fold decrease in SW480 colon cancer cells. A similar differential activity was seen in liver cancer cells (HepG2, Huh7, and Hep3B). Overexpression of {beta}-catenin produced a dose-dependent decrease in NF-{kappa}B reporter activity and decreased cytokine mixture–induced hiNOS promoter activity. Gel shift for TNF{alpha}-induced hiNOS NF-{kappa}B activation showed decreased p50 binding and decreased NF-{kappa}B reporter activity in the {beta}-catenin–mutant HA{beta}18 cells. Conversely, enhanced p50 binding and increased NF-{kappa}B reporter activity were seen in HA{beta}85 cells, which lack {beta}-catenin signaling. Coimmunoprecipitation confirmed that {beta}-catenin complexed with both p65 and p50 NF-{kappa}B proteins. NF-{kappa}B–dependent Traf1 protein expression also inversely correlated with the level of {beta}-catenin. Furthermore, SW480 cells stably transformed with wild-type adenomatous polyposis coli showed decreased {beta}-catenin protein and increased TNF{alpha}-induced p65 NF-{kappa}B binding as well as iNOS and Traf1 expression. Finally, {beta}-catenin inversely correlated with iNOS and Fas expression in vivo in hepatocellular carcinoma tumor samples. Our in vitro and in vivo data show that {beta}-catenin signaling inversely correlates with cytokine-induced hiNOS and other NF-{kappa}B–dependent gene expression. These findings underscore the complex role of Wnt/{beta}-catenin, NF-{kappa}B, and iNOS signaling in the pathophysiology of inflammation-associated carcinogenesis. [Cancer Res 2009;69(9):3764–71]

Key Words: iNOS, nitric oxide, NF-{kappa}B, Wnt?{beta}-catenin, hepatocellular carcinoma







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.